• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三级淋巴结构的成熟度和密度与肿瘤转移及化疗反应相关。

Maturity and density of tertiary lymphoid structures associate with tumor metastasis and chemotherapy response.

作者信息

Jiang Sutian, Liao Xuhui, Ding Xuzhong

机构信息

Department of Pathology, Lishui People's Hospital, Lishui, China.

Department of Gastrointestinal Surgery, Lishui People's Hospital, Lishui, China.

出版信息

Front Med (Lausanne). 2024 Oct 18;11:1435620. doi: 10.3389/fmed.2024.1435620. eCollection 2024.

DOI:10.3389/fmed.2024.1435620
PMID:39493723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11527684/
Abstract

BACKGROUND

Tertiary Lymphoid Structures (TLSs) are abnormal clusters of immune cells that form in tissues not normally associated with the immune system, usually in cases of long-lasting inflammation, like cancer. TLSs have been suggested as a potential prognostic indicator in various cancer types.

METHODS

We retrospectively enrolled 223 gastric cancer (GC) patients who had surgical resections in this study. We utilized hematoxylin and eosin (HE) staining to detect the presence, abundance, and maturity of TLSs. In serial sections, we used immunohistochemistry to examine the cellular composition of TLSs.

RESULTS

The pathological review identified TLSs in 95.1% of the tumors, lymphoid aggregates in 79.8%, primary follicles in 45.7%, and lymphoid aggregates in 95.1% of the cases. Based on Kaplan-Meier curves, the maturation and abundance of TLSs contributed to longer disease-free survival (DFS) and overall survival (OS). In addition, the density of TLSs was strongly associated with the occurrence of tumor metastases and the response to adjuvant chemotherapy.

CONCLUSIONS

We validated the prognostic value of TLSs in GC patients in both independent cohorts, and the maturity and density of TLS correlated with tumor metastasis. In addition, TLS may reflect sustained antitumor potency, which has important implications for adjuvant chemotherapy.

摘要

背景

三级淋巴结构(TLSs)是在通常与免疫系统无关的组织中形成的异常免疫细胞簇,通常发生在诸如癌症等持续性炎症的情况下。TLSs已被认为是多种癌症类型中的一种潜在预后指标。

方法

我们回顾性纳入了本研究中223例接受手术切除的胃癌(GC)患者。我们利用苏木精和伊红(HE)染色来检测TLSs的存在、丰度和成熟度。在连续切片中,我们使用免疫组织化学来检查TLSs的细胞组成。

结果

病理检查发现95.1%的肿瘤中有TLSs,79.8%有淋巴聚集,45.7%有初级滤泡,95.1%的病例中有淋巴聚集。根据Kaplan-Meier曲线,TLSs的成熟度和丰度有助于延长无病生存期(DFS)和总生存期(OS)。此外,TLSs的密度与肿瘤转移的发生及辅助化疗的反应密切相关。

结论

我们在两个独立队列中验证了TLSs对GC患者的预后价值,且TLSs的成熟度和密度与肿瘤转移相关。此外,TLSs可能反映了持续的抗肿瘤效力,这对辅助化疗具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b851/11527684/8444a8aad0f5/fmed-11-1435620-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b851/11527684/891cac619a23/fmed-11-1435620-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b851/11527684/d3fb206daa7d/fmed-11-1435620-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b851/11527684/6b6e0577ea23/fmed-11-1435620-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b851/11527684/8444a8aad0f5/fmed-11-1435620-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b851/11527684/891cac619a23/fmed-11-1435620-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b851/11527684/d3fb206daa7d/fmed-11-1435620-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b851/11527684/6b6e0577ea23/fmed-11-1435620-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b851/11527684/8444a8aad0f5/fmed-11-1435620-g004.jpg

相似文献

1
Maturity and density of tertiary lymphoid structures associate with tumor metastasis and chemotherapy response.三级淋巴结构的成熟度和密度与肿瘤转移及化疗反应相关。
Front Med (Lausanne). 2024 Oct 18;11:1435620. doi: 10.3389/fmed.2024.1435620. eCollection 2024.
2
Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma.滤泡样三级淋巴结构:喉鳞状细胞癌患者预后和免疫治疗反应的潜在生物标志物。
Front Immunol. 2023 Jan 27;14:1096220. doi: 10.3389/fimmu.2023.1096220. eCollection 2023.
3
Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma.三级淋巴结构有利于食管鳞癌切除术后的预后。
J Pathol Clin Res. 2022 Sep;8(5):422-435. doi: 10.1002/cjp2.281. Epub 2022 Jun 16.
4
Intra-Tumoral Secondary Follicle-like Tertiary Lymphoid Structures Are Associated with a Superior Prognosis of Overall Survival of Perihilar Cholangiocarcinoma.肿瘤内二级滤泡样三级淋巴结构与肝门部胆管癌总生存期的良好预后相关。
Cancers (Basel). 2022 Dec 12;14(24):6107. doi: 10.3390/cancers14246107.
5
Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.食管鳞癌中三级淋巴结构的临床意义。
BMC Cancer. 2022 Jun 24;22(1):699. doi: 10.1186/s12885-022-09777-w.
6
Infiltrating characteristics and prognostic value of tertiary lymphoid structures in resected gastric neuroendocrine neoplasm patients.胃神经内分泌肿瘤患者切除标本中三级淋巴结构的浸润特征及预后价值
Clin Transl Immunology. 2024 Feb 5;13(2):e1489. doi: 10.1002/cti2.1489. eCollection 2024.
7
Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.肿瘤内三级淋巴结构与肝细胞癌早期复发风险低相关。
J Hepatol. 2019 Jan;70(1):58-65. doi: 10.1016/j.jhep.2018.09.003. Epub 2018 Sep 11.
8
Tertiary lymphoid structures in pulmonary metastases of microsatellite stable colorectal cancer.结直肠微卫星稳定型肺转移瘤中的三级淋巴结构。
Virchows Arch. 2023 Jul;483(1):21-32. doi: 10.1007/s00428-023-03577-8. Epub 2023 Jun 20.
9
Density of tertiary lymphoid structures predicts clinical outcome in breast cancer brain metastasis.三阴性淋巴结构密度可预测乳腺癌脑转移的临床结局。
J Immunother Cancer. 2024 Jul 27;12(7):e009232. doi: 10.1136/jitc-2024-009232.
10
Tertiary lymphoid structures combined with biomarkers of inflammation are associated with the efficacy of neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: A retrospective study.三级淋巴结构联合炎症生物标志物与可切除性非小细胞肺癌新辅助免疫化疗疗效相关:一项回顾性研究。
Thorac Cancer. 2024 Jan;15(2):172-181. doi: 10.1111/1759-7714.15175. Epub 2023 Dec 6.

本文引用的文献

1
Prediction values of tertiary lymphoid structures in the prognosis of patients with left- and right-sided colon cancer: a multicenter propensity score-matched study.三级淋巴结构预测左、右半结肠癌患者预后的价值:一项多中心倾向评分匹配研究。
Int J Surg. 2023 Aug 1;109(8):2344-2358. doi: 10.1097/JS9.0000000000000483.
2
Development and Validation of a Machine Learning Model for Detection and Classification of Tertiary Lymphoid Structures in Gastrointestinal Cancers.开发和验证一种用于检测和分类胃肠道癌中三级淋巴结构的机器学习模型。
JAMA Netw Open. 2023 Jan 3;6(1):e2252553. doi: 10.1001/jamanetworkopen.2022.52553.
3
Preventive effect of tertiary lymphoid structures on lymph node metastasis of lung adenocarcinoma.
三级淋巴结构对肺腺癌淋巴结转移的预防作用。
Cancer Immunol Immunother. 2023 Jun;72(6):1823-1834. doi: 10.1007/s00262-022-03353-8. Epub 2023 Jan 23.
4
T follicular helper cells in cancer.肿瘤中的滤泡辅助 T 细胞。
Trends Cancer. 2023 Apr;9(4):309-325. doi: 10.1016/j.trecan.2022.12.007. Epub 2023 Jan 14.
5
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?癌症中三级淋巴结构中B细胞的激活:抗肿瘤还是自身免疫?
Semin Immunol. 2023 Jan;65:101703. doi: 10.1016/j.smim.2022.101703. Epub 2022 Dec 5.
6
Identifying immune cells-related phenotype to predict immunotherapy and clinical outcome in gastric cancer.鉴定免疫细胞相关表型以预测胃癌的免疫治疗和临床结局。
Front Immunol. 2022 Aug 11;13:980986. doi: 10.3389/fimmu.2022.980986. eCollection 2022.
7
Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities.多模块分析肝内胆管癌免疫亚群揭示了不同的治疗弱点。
J Immunother Cancer. 2022 Jul;10(7). doi: 10.1136/jitc-2022-004892.
8
Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma.三级淋巴结构有利于食管鳞癌切除术后的预后。
J Pathol Clin Res. 2022 Sep;8(5):422-435. doi: 10.1002/cjp2.281. Epub 2022 Jun 16.
9
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome.B 细胞和三级淋巴结构作为肿瘤免疫微环境和临床结局的决定因素。
Nat Rev Clin Oncol. 2022 Jul;19(7):441-457. doi: 10.1038/s41571-022-00619-z. Epub 2022 Apr 1.
10
Tertiary lymphoid structures critical for prognosis in endometrial cancer patients.三级淋巴结构对子宫内膜癌患者的预后至关重要。
Nat Commun. 2022 Mar 16;13(1):1373. doi: 10.1038/s41467-022-29040-x.